Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Naltrexone Treatment for Prolonged Grief Disorder (PGD)

Status

Terminated

NCT ID

NCT04547985

This is a study to see how effective oral naltrexone is as treatment for prolonged grief disorder (PGD). Participants will take their assigned medication for 8 weeks, with monthly visits to assess symptom severity, social connectedness, and adverse reactions.

Intervention

Naltrexone HCl 50 MG Oral Tablet, Placebo

Condition

Prolonged Grief Disorder

Investigators

Holly G Prigerson, PhD

See list of participating sites